NCT Number: NCT02746484
The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care.
Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program
Looking for future studies?
Notify Me65 year–85 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
Time frame: change from baseline after 8 weeks (aMCI/AD subjects)
Activities of Daily Living Inventory (ADCS/ADL)
Time frame: change from baseline after 8 weeks (aMCI/AD subjects)
Neuropsychiatric Inventory (NPI) score
Time frame: change from baseline after 8 weeks (aMCI/AD subjects)
Free and Cued Selective Recall Test (FCSRT) score
Time frame: change from baseline after 8 weeks (aMCI/AD subjects)
Fluency score
Time frame: change from baseline after 8 weeks (aMCI/AD subjects)
Trail Making Test (TMT) score
Time frame: change from baseline after 8 weeks (aMCI/AD subjects)
Dementia Quality of Life (D-QoL) Instrument
Time frame: change from baseline after 8 weeks (aMCI/AD subjects)
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
Time frame: change from baseline after 12 months (aMCI/AD subjects)
Montreal Cognitive Asssessment (MoCA) score
Time frame: change from baseline after 12 months (aMCI/AD subjects)
Activities of Daily Living Inventory (ADCS/ADL)
Time frame: change from baseline after 12 months (aMCI subjects)
conversion rate score
Time frame: change from baseline after 12 months (aMCI/AD subjects)
Free and Cued Selective Recall Test (FCSRT) score
Time frame: change from baseline after 12 months (aMCI/AD subjects)
Fluency score
Time frame: change from baseline after 12 months
Trail Making Test (TMT) score
Time frame: change from baseline after 12 months
Dementia Quality of Life (D-QoL) Instrument
Time frame: change from baseline after 12 months
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
Time frame: change from baseline after 8 weeks and after 12 months
Psychological Well-Being (PWB) scale
Time frame: change from baseline after 8 weeks and after 12 months
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
Time frame: change from baseline after 8 weeks and after 12 months
Caregiver Burden Inventory (CBI)
Time frame: change from baseline after 8 weeks and after 12 months
Positive and Negative Affect Schedule (PANAS)
Fondazione Don Carlo Gnocchi ETS
Other
ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07069530
Alzheimer Disease, Alzheimer Disease (AD)
Fort Myers, Florida, United States
View Trial DetailsNCT01071044
Chronic Disease, Chronic Fatigue Syndrome
Rochester Hills, Michigan, United States
View Trial DetailsNCT07029048
COVID 19, COVID-19
Astana, Kazakhstan
View Trial DetailsNCT05822596
Cognition Disorders, Cognitive Dysfunction
Hong Kong
View Trial Details